-+ 0.00%
-+ 0.00%
-+ 0.00%

Brookline Capital Initiates Coverage On Ernexa Therapeutics with Buy Rating, Announces Price Target of $30

Benzinga·05/07/2026 19:28:26
Listen to the news
Brookline Capital initiates coverage on Ernexa Therapeutics (NASDAQ:ERNA) with a Buy rating and announces Price Target of $30.